active TB at some point in their lives either shortly after initial infection or as a progression from a latent infection (2) . Children and individuals with an impaired immune system generally have a higher risk of developing active TB (3) . M. tuberculosis is transmitted through aerosol droplets to the lung alveoli, where the pathogen infects alveolar macrophages and subsequently dendritic cells (DC), neutrophils, and macrophages in the lung interstitium (4) . Activation of naïve TB-specific T cells depends on the migration of infected DC from the lungs to the mediastinal lymph nodes (5) (6) (7) . DC present M. tuberculosis antigens for the T cells and dependent on the cytokines present during the T cell receptor-mediated activation process, the CD4 + T helper (Th) cells differentiate to different types of effector cells in the lymph nodes (8, 9) . Macrophages and DC become activated by stimulation through the toll-like receptors (TLR)2, 4, and 9 in response to M. tuberculosis and start production of pro-inflammatory cytokines such as tumor necrosis factor α (TNFα), interleukin (IL)-1β, and IL-12 (10) . IL-12 plays a major role in the differentiation of Th cells to interferon γ (IFNγ)-producing Th1 effector cells by signaling through the IL-12 receptor (IL-12R), which results in phosphorylation and dimerization of signal transducer and activator of transcription (STAT)4. STAT4 then translocates to the nucleus and binds to regulatory elements of target genes, including the Th1 master transcription factor TBX21, IL12Rβ2, and IFNG. IFNγ induces phosphorylation of STAT1 that further activates transcription of TBX21 and IL12Rβ2, which in turn act in a positive-feedback loop to amplify Th1 differentiation (8, 9) . The resulting Th1 effector cells migrate out of the lymph nodes and are then recruited to the sites of infection.
In the latent state, M. tuberculosis is contained by the immune system in granulomas consisting mainly of infected macrophages surrounded by IFNγ-producing Th1 cells (2, 11) . The importance of IFNγ in the immune response to mycobacteria is well established in both humans and mice. Thus, individuals with a mutation in genes related to the production of or response to IFNγ have a high susceptibility to mycobacterial infection (12) (13) (14) (15) (16) . Likewise, mice that lack IFNγ or the IFNγ receptor are extremely susceptible to TB (17, 18) . IFNγ is crucial for activation of macrophages and the formation and containment of M. tuberculosis in granulomas (13, 18) . A central role of IFNγ is to enhance the ability of macrophages to kill intracellular pathogens such as M. tuberculosis (19, 20) . The antimicrobial peptide cathelicidin plays an important role in the ability of macrophages to kill bacteria, and it has been reported that IFNγ increases the expression of cathelicidin in human monocytes and macrophages (21) (22) (23) . Interestingly, these studies found that vitamin D is required for IFNγ-mediated enhancement of cathelicidin. This is in good agreement with several studies showing that vitamin D deficiency is associated with impaired expression of cathelicidin and increased susceptibility to infectious diseases, including TB (24) (25) (26) (27) (28) (29) (30) , and it could be an important mechanism explaining the beneficial role of vitamin D in TB prevention and treatment (31, 32) . In sharp contrast to this, several studies have shown that vitamin D inhibits the production of IFNγ in T cells (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) 
cell culture
Mononuclear cells from blood were isolated by Lymphoprep (Axis-Shield, Oslo, Norway) density-gradient centrifugation using SepMate™ tubes (86460, Stemcell Technologies, Grenoble, France) from healthy donors after obtaining informed, written consent in accordance with the Declarations of Helsinki principles for research involving human objects. The study was approved by The Committees of Biomedical Research Ethics for the Capital Region in Denmark (H-16033682). Naïve CD4 + T cells were isolated and cultured as previously described (47) . The purified naïve CD4 + T cells were cultured in serum-free X-VIVO 15 medium (BE02-060F, Lonza, Verviers, Belgium) at 37°C, 5% CO2 at a cell concentration of 1 × 10 6 cells/ml in flatbottomed 24-well tissue culture plates (142475) from Nunc and stimulated with Dynabeads human T-activator CD3/CD28 beads (111.31D, Life Technologies, Grand Island, NY, USA) at a cell to bead ratio of 5:2 for up to 3 days. Cells present in the culture after 3 days were defined as activated T cells. In some experiments, 25(OH)D3, 1,25(OH)2D3, or recombinant human IL-12 (219-IL, R&D Systems) was added at the indicated concentrations to the medium during the stimulation period. In Th1 polarization studies, purified naïve CD4 + T cells were cultured and stimulated as described above in the presence of recombinant human IL-12 (10 ng/ml) plus human IL-4 antibody (4 µg/ml, MAB204, R&D Systems). In some experiments, cells were counted after 72 h of activation using the automated cell counter NucleoCounter ® NC-100™ from Chemometec.
Monocytes used for generation of monocyte-derived DC were isolated from blood mononuclear cells using EasySep Human Monocyte Enrichment Kit (19059, Stemcell Technologies) according to the manufacturer's protocol. Following isolation, monocytes were cultured in flat-bottomed six-well tissue culture plates (140675, Nunc) at a cell concentration of 5 × 10 5 cells/ml for 6 days in medium (RPMI-1640, R5886, Sigma-Aldrich) with penicillin, streptomycin, l-glutamine, and 10% heat-inactivated FBS (10082-147, Gibco) supplemented with GM-CSF and IL-4 (both 50 ng/ml, AF-HDC, PeproTech) with a re-supplementation + T cells were purified from a different donor as described above and co-cultured with 1 × 10 5 cells/ml DC in a ratio of 1:10 DC to T cells in flat-bottomed 24-well tissue culture plates for another 6 days in X-VIVO 15 medium.
elisa
IFNγ and IL-13 concentrations in the supernatants were determined by ELISA according to the manufacturer's protocol (Ready-Set-Go; eBioscience).
QPcr mRNA expression was measured by real-time RT-PCR (QPCR). For this, cells were lysed in TRI reagent (T9424, Sigma-Aldrich) followed by addition of 1-bromo-3-chloropropane (B9673, Sigma Aldrich) to separate the sample into an aqueous and an organic phase. The RNA was precipitated from the aqueous phase using isopropanol supplemented with glycogen (10814-010, Invitrogen), washed with ethanol, and dissolved in RNase free water. Equal amounts of total RNA were used for complementary DNA (cDNA) synthesis using the high-capacity RNA-tocDNA™ Kit from Applied Biosystems (4387406) according to manufacturer's protocol. For QPCR, 12.5 ng cDNA was mixed with TaqMan ® Universal Master Mix II with UNG (4440038, Applied Biosystems), the target primer, and the eukaryotic 18 S rRNA primer (1509311, Applied Biosystems). The samples were run on a Stratagene Mx3000P™ real-time PCR machine (Agilent Technologies). The thermal profile was set to 2 min at 50°C, a 10 min hot start at 95°C, followed by cycles of 15 s at 95°C and 1 min at 60°C. Signal intensity was measured at the end of the 60°C step, and the threshold cycle values were related to eukaryotic 18S rRNA. The following primers were used; IFNG (Hs00989291_m1), CYP27B1 (Hs01096154_m1), vitamin D receptor (VDR) (Hs01045840_m1), CYP24A1 (Hs00167999_ m1), TBX21 (Hs00203436_m1), IL-12RB2 (Hs00155486_m1), CXCL9 (Hs00171065_m1), CXCL10 (Hs00171042_m1), and CAMP (cathelicidin antimicrobial peptide) (Hs00189038_m1) all from Applied Biosystems.
Western Blot analysis
For Western blot analysis, whole cell lysates were obtained by treatment of the cells with lysis buffer (50 mM Tris pH 7.5, 150 mM NaCl, 1 mM MgCl2) supplemented with 1% Triton X-100, 1× Protease inhibitor cocktail (5872S, Cell Signaling Technology, Beverly, MA, USA) and 5 mM EDTA. The samples were run under reducing conditions on polyacrylamide gels for 2 h at 120 volt in 1× NuPAGE MOPS SDS Running buffer (K855, Amresco, Solon, OH, USA) in an XCell SureLock ® Mini-Cell Module from Life Technologies. The proteins were transferred to nitrocellulose membrane sheets (LC2001, Life Technologies) in 1× NuPAGE Transfer buffer (NP0006-1, Life Technologies) supplemented with 10% ethanol for 60 min at 50 V in an XCell II™ Blot Module from Life Technologies. The membranes were subsequently blocked for 60 min in Tris-buffered saline supplemented with 5% milk powder (70166, Sigma-Aldrich) and 0.1% Tween 20 (P1379, Sigma-Aldrich) and incubated at 4°C for 24 h with primary antibodies diluted in Tris-buffered saline supplemented with 5% bovine serum albumin (A4503, Sigma-Aldrich) and 0.1% Tween 20. The membranes were washed and the proteins visualized following 60 min incubation at room temperature with secondary HRP-rabbit anti-mouse Ig and HRP-swine anti-rabbit Ig using ECL (RPN2232, Sigma Aldrich) technology. The antiphospho-STAT1 (9171) and phospho-STAT4 (5267) antibodies were from Cell Signaling Technologies, the anti-STAT1 (SC-346), STAT4 (SC-486), and VDR (SC-13133) antibodies were from Santa Cruz Biotechnology, Santa Cruz, CA, USA and the anti-GAPDH (Ab9485) was from Abcam, Cambridge, UK. For band density quantification, ECL-exposed sheets were analyzed in a ChemiDoc MP Imaging System from Bio-Rad.
statistical analysis
Data are shown as mean ± SEM. Statistical analyses were performed using Student's t-test with a 5% significance level, paired observations, and equal variance. * indicates p ≤ 0.05. (24, 46) . To study the direct effect of 25(OH)D3 and 1,25(OH)2D3 on IFNγ production in human Th cells under strictly defined conditions, we isolated naïve CD4 + T cells and stimulated them with human T-activator CD3/CD28 beads in serum-free medium in the absence or presence of 25(OH)D3 or 1,25(OH)2D3. We found that 1,25(OH)2D3 strongly inhibited IFNγ production (~15-fold) at physiological concentrations (60-110 pM) ( Figure 1A) . Furthermore, we found that 25(OH) D3 at physiological concentrations (50-125 nM) inhibited IFNγ production to the same degree as 1,25(OH)2D3 (Figure 1A) , which confirms that T cells have the ability to convert the inactive 25(OH)D3 to the active 1,25(OH)2D3 (46, 47) . It is well known that anti-CD3/CD28 bead stimulation promotes expansion of CD4 + T cells (48) . To investigate whether the lower levels of IFNγ in vitamin D-treated cells could be attributed to fewer cells, we stimulated CD4
+ T cells for 72 h in the presence or absence of 100 nM 25(OH)D3 and subsequently counted the cells using an automated cell counter. At this time point, we found that there were approximately 1.5-fold more CD4 + T cells in the cultures compared to the initial cell number independently of the absence or presence of vitamin D (Figure 1B) . To exclude a general toxic effect of vitamin D on the T cells, we subsequently measured secretion of IL-13 in parallel with IFNγ. We found that vitamin D increased IL-13 secretion in parallel with its inhibition of IFNγ secretion ( Figure 1C) . Thus, the decreased levels of IFNγ were not caused by a reduced cell number or a toxic effect of vitamin D but most likely by a specific effect of vitamin D on IFNγ secretion. Previous studies have reported that 1,25(OH)2D3 inhibits production of IFNγ and augment the production of IL-4, and based on these observations it has been concluded that vitamin D restrains Th1 differentiation and promotes Th2 differentiation (41) (42) (43) (44) (45) . However, to our knowledge, the effect of physiological concentrations of vitamin D on IFNγ production in T cells activated under Th1-inducing conditions has not been reported. To study this, we activated naïve CD4 + T cells in the absence or presence of IL-12 and 25(OH)D3. In the absence of 25(OH)D3, IL-12 increased IFNγ production ( Figure 1D) . Interestingly, although 25(OH)D3 at physiological concentrations did reduce IFNγ production in IL-12 treated cells, these cells still produced equal amounts of IFNγ as T cells activated in the absence of 25(OH)D3 and IL-12 ( Figure 1D) + T cells in the presence of 100 nM 25(OH)D3 in the absence or presence of IL-12 and measured the expression levels of CYP27B1 mRNA in the cells. We found that IL-12 did not influence the expression of CYP27B1 (Figure 2A) . Furthermore, we directly measured the production of 1,25(OH)2D3 in the supernatants and found that IL-12 did not affect the production of 1,25(OH)2D3 (Figure 2B) . Another way IL-12 might counteract vitamin D-mediated inhibition of IFNγ production in CD4 + T cells could be by inhibiting the expression or function of the VDR. However, we found that IL-12 slightly increased VDR expression on the mRNA level ( Figure 2C) . To further investigate whether IL-12 affected VDR expression, we determined the effect of IL-12 on VDR protein levels. We did not observe any significant effect of IL-12 on VDR expression at the protein level ( Figure 2D) . CYP24A1 is the enzyme that initiates degradation of 1,25(OH)2D3, and CYP24A1 expression is dependent on functional 1,25(OH)2D3/VDR complexes. Consequently, we measured the CYP24A1 levels in cells treated with or without IL-12. We found that the cells produced very high amounts of CYP24A1 in the presence of 100 nM 25(OH)D3 (approximately 100.000-fold upregulated compared to unstimulated T cells) although IL-12 slightly reduced CYP24A1 expression ( Figure 2E) . Taken together, these experiments indicated that IL-12 does not counteract vitamin D-mediated inhibition of IFNγ production in CD4 + T cells by reducing their ability to 
Vitamin D Does not Prevent Th1 Differentiation
Due to the inhibition of IFNγ production, it has been suggested that vitamin D impedes differentiation of Th1 cells. However, whether vitamin D actually inhibits Th1 differentiation is still not known. Figure 3C ) and they produced high levels of IFNγ ( Figure 1D ). In line with the strong production of IFNγ, we found that vitamin D did not affect STAT1 phosphorylation significantly during T cell activation ( Figure 3D) . Likewise, STAT4 phosphorylation was not significantly affected of vitamin D (Figure 3E) .
IFNγ itself plays an important role during Th1 differentiation as STAT1 activated by IFNγ further activates transcription of TBX21 and IL12Rβ2 (8, 9) . We have previously demonstrated that naïve human CD4 + T cells do not express the VDR but that they start to express it 24-48 h after TCR/CD28 stimulation (46, 49) . This suggests that vitamin D cannot affect IFNγ production in the early stages of T cell activation due to the lack of VDR. To study the effect of 25(OH)D3 and Th1-inducing conditions on the early kinetics of VDR expression, we stimulated naïve CD4 + T cells for 12, 24, and 48 h in the presence or absence of 25(OH)D3 and Th1-inducing conditions. We could confirm that only very low levels of VDR are present after 12 and 24 h of stimulation, and that substantial VDR expression levels are found after 48 h of stimulation ( Figure 4A ). In agreement, we found that at 12 h of stimulation, vitamin D did not influence IFNγ production neither in cells activated in the absence or presence of Th1 conditions ( Figure 4B ). In contrast, Th1 conditions acted rapidly with increased production of IFNγ already 12 h after stimulation ( Figure 4B) . After 24 h of stimulation, a minor inhibitory effect of vitamin D on IFNγ production was seen (Figure 4C) , and after 48 h vitamin D substantially inhibited IFNγ production ( Figure 4D) . These experiments indicated that IL-12-mediated signaling is initiated rapidly after initial T cell stimulation with increased IFNγ production as a consequence, and that this takes place before the VDR is expressed at sufficiently high levels to inhibit IFNγ production. These observations support that CD4 + T cells activated under Th1-inducing conditions start differentiation toward Th1 cells even in the presence of vitamin D.
Vitamin D is required for concomitant Production of iFnγ and cathelicidin in Dc-T cell co-cultures
Activation of naïve TB-specific T cells depends on the migration of infected DC from the lungs to the mediastinal lymph nodes where the DC present TB-derived antigens for the T cells (5-7). It has been suggested that antigen-presenting cells mediate the vitamin D-induced inhibition of IFNγ production in T cells (36, 38, 40) , and the absence of antigen-presenting cells in our experimental set up could maybe explain why we observed IFNγ production in purified T cells stimulated in the presence of vitamin D and IL-12. To investigate this possibility, we cultured naïve CD4 + T cells with allogeneic DC for 6 days with or without 25(OH)D3 in the absence or presence of Th1-inducing conditions and subsequently measured IFNγ expression and production. Vitamin D strongly inhibited IFNγ mRNA expression (~15-fold) ( Figure 5A ) and production (~20-fold) ( Figure 5B) in the absence of Th1-inducing conditions. Th1-inducing conditions increased IFNγ expression and production and counteracted the inhibitory effect of vitamin D. Thus, vitamin D only inhibited IFNγ mRNA expression ~2-fold and IFNγ production ~3-fold in the presence of Th1-inducing conditions (Figures 5A,B) . Interestingly, IFNγ expression and production in cells cultured with vitamin D under Th1-inducing conditions were at least as high as in cells cultured without vitamin D and Th1-inducing conditions (Figures 5A,B) . This indicated that DC do not shut down IFNγ production in T cells in the presence of vitamin D. Taken together, we could conclude that vitamin D strongly inhibits IFNγ expression and production in T cells in the absence of Th1-inducing conditions, and that Th1-inducing conditions partially rescue IFNγ production in the presence of vitamin D independently on the presence or absence of DC. Cellular responses mediated by IFNγ are primarily caused by gene expression modulation. Primary IFNγ-responsive genes are induced early by binding of STAT1 dimers to gammaactivating sequences in the promoter of target genes such as IRF1, CXCL9, and CXCL10 (50) . To study whether the levels of IFNγ produced in Th1 cells in the presence of vitamin D were sufficient to affect IFNγ-responsive genes, we measured the expression of CXCL9 and CXCL10 in the same co-cultures as described above. We found that vitamin D reduced CXCL9 and CXCL10 expression ~110 and ~25-fold in Th0 cells, respectively (Figures 5C,D) . As the importance of IFNγ in the immune response to mycobacteria is well established, it is puzzling why vitamin D, associated with a beneficial role in TB prevention and treatment, reduces IFNγ production. Cathelicidin plays an important role in the killing of especially intracellular pathogens such as M. tuberculosis in macrophages (51) . Furthermore, it has been shown that cathelicidin expression is dependent on vitamin D, and that IFNγ increases the synthesis of cathelicidin in macrophages (21) (22) (23) . To study how cathelicidin is regulated in DC, we cultured naïve CD4 + T cells with allogeneic DC for 6 days as described above with or without 25(OH)D3 in the absence or presence of Th1-inducing conditions and subsequently measured cathelicidin expression. We found that cathelicidin upregulation was absolutely dependent on vitamin D but independent of Th1-inducing conditions (Figure 5E ). This indicated that vitamin D without IFNγ is sufficient to induce cathelicidin upregulation, and that IFNγ without vitamin D does not affect cathelicidin expression in DC.
Vitamin D counteracts the inhibitory effect of M. tuberculosis on cathelicidin expression in Dc
Previous studies have demonstrated that IFNγ acts in synergy with TLR2 ligands to upregulate cathelicidin expression in human monocytes and macrophages (21, 22) . To determine how vitamin D, IFNγ, and HKMT/TLR2 ligands affect cathelicidin expression in DC, we incubated DC in the absence or presence of 25(OH)D3, IFNγ, and HKMT or Pam3CSK4, and measured the expression of cathelicidin. Surprisingly, we found that HKMT and Pam3CSK4 significantly downregulated cathelicidin expression both in the absence and presence of vitamin D (Figure 6A) . In contrast, vitamin D strongly upregulated cathelicidin expression both in the absence and presence of HKMT or Pam3CSK4. Although HKMT and Pam3CSK4 downregulated cathelicidin expression ~13-and ~10-fold in the presence of vitamin D, respectively, the expression of cathelicidin was still ~215-and ~120-fold higher in DC stimulated with HKMT/ Pam3CSK4 in the presence of vitamin D than in the absence of vitamin D (Figure 6A) . IFNγ by itself did not affect cathelicidin expression.
To determine whether the HKMT/Pam3CSK4-induced inhibition of cathelicidin expression was caused by a reduced ability to produce or respond to 1,25(OH)2D3, we incubated DC in the absence or presence of 25(OH)D3, IFNγ, and HKMT/Pam3CSK4 and measured the expression of CYP27B1, VDR, and CYP24A1, and the production of 1,25(OH)2D3. We found that HKMT/Pam3CSK4 increased CYP27B1 expression, especially in the presence of 25(OH)D3 (Figure 6B) . In 
DiscUssiOn
In this study, we show that vitamin D does not block differentiation of naïve human CD4 + T cells to Th1 cells and that IL-12 partially rescues IFNγ production in T cells exposed to vitamin D. Furthermore, we demonstrate that HKMT/TLR2 ligands strongly downregulate cathelicidin expression in DC and that vitamin D counteracts this by upregulating cathelicidin expression.
Since the first studies on the effect of vitamin D on IFNγ production in human T cells (33, 34) several studies have confirmed that vitamin D inhibits IFNγ production in both human and mouse T cells (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) . Some studies found that this was an indirect effect mediated via antigen-presenting cells (36, 38, 40) , whereas others found a direct effect of vitamin D on T cells (41) (42) (43) . We found that both the inactive and the active form of vitamin D inhibit IFNγ production in purified CD4 + T cells. Thus, our study confirms that activated T cells can convert inactive vitamin D to active vitamin D, and that vitamin D has a direct effect on human T cells. This is in good accordance with expression of both CYP27B1 and the VDR in activated human T cells (46, 47, 49, 52) . Based on the impaired IFNγ production and increased IL-4 production in T cells exposed to vitamin D, it has been concluded that vitamin D restrains Th1 differentiation and promotes Th2 differentiation. However, only few studies have investigated whether vitamin D actually affects the master transcription factors TBX21 and GATA3 regulating Th1 and Th2 differentiation. One study found that although 1,25(OH)2D3 inhibited IFNγ production, it had no effect on the levels of TBX21 and GATA3 in mouse T cells activated under Th0, Th1, or Th2 conditions (37) . Another study found a very discrete increase in GATA3 expression in mouse T cells activated in the presence of 1,25(OH)2D3 under Th0 conditions, but they did not study TBX21 expression nor the effect of Th1 conditions (53 (54) and that the fraction of IFNγ-producing T cells is not reduced in T cells activated in the presence of vitamin D under Th1 conditions (55) . The kinetic studies illustrated in Figures 3 and 4 in this study also strongly support that vitamin D does not inhibit Th1 differentiation. The VDR is not or only weakly expressed in T cells for the first 24 h of stimulation, and consequently vitamin D cannot affect IFNγ expression or production at these early time points. In contrast, IL-12 signaling is efficient already shortly after T cell activation and augments IFNγ production and initiates Th1 differentiation.
It has been demonstrated that the promoter of the human cathelicidin gene contains a consensus vitamin D response element, and that cathelicidin is upregulated by vitamin D (56, 57) . Shortly after these studies, it was found that signaling through TLR2 induced upregulation of CYP27B1 and the VDR in human monocytes and macrophages but not in DC (24) . Furthermore, upregulation of cathelicidin and growth inhibition of M. tuberculosis were seen if the cell culture media was supplemented with 25(OH)D3 (24) . A subsequent study confirmed that the vitamin D-mediated antimicrobial activity against M. tuberculosis in the human monocytic cell line THP-1 was dependent on cathelicidin (51) . In accordance with Liu et al. (24) , we found that HKMT/TLR2 triggering did not significantly affect VDR expression in DC. In contrast to VDR, we found that the TLR2 ligand Pam3CSK4 and especially HKMT upregulated CYP27B1 expression and 1,25(OH)2D3, production in the presence of 25(OH)D3. However, although HKMT/Pam3CSK4 upregulated CYP27B1, untreated DC still expressed high levels of CYP27B1. Accordingly, we found that even untreated DCs have a high capacity to convert 25(OH)D3 to 1,25(OH)2D3, and to respond to 1,25(OH)2D3 with strong upregulation of cathelicidin and CYP24A1 expression. In sharp contrast to studies finding that TLR2 ligands upregulated cathelicidin in human monocytes and macrophages in a vitamin D-dependent manner (21, 22, 24) , we found that HKMT profoundly downregulated cathelicidin in human DC. Although HKMT is described as a primary TLR2 ligand, it has been reported that M. tuberculosis stimulates a range of other receptors, including TLR4 and 9 (10). However, we found that the TLR2 ligand Pam3CSK4 mimicked HKMT in regard to cathelicidin downregulation, although not quite as efficiently as HKMT. TLR4 triggering also resulted in cathelicidin downregulation and we could conclude that M. tuberculosis can downregulate cathelicidin expression in DC through signaling via TLR2 and most likely additional TLR. As for cathelicidin expression, different responses between monocytes/macrophages and DC to TLR2 signaling have been reported concerning MHC class II expression. Thus, whereas TLR2 signaling inhibits MHC class II expression in macrophages, it enhances MHC class II expression in DC (58) . Interestingly, although the paradigm is that TLR2 signaling increases cathelicidin expression in human monocytes and macrophages (21, 22, 24) , two papers have actually found that TLR2 signaling reduces cathelicidin expression in human monocytes in accordance with what we find in human DC (59, 60) .
M. tuberculosis uses various strategies to evade antimicrobial mechanisms of macrophages, including inhibition of phagosomelysosome fusion, antigen presentation, MHC class II expression, autophagy, and cytokine production (61) . Interestingly, many of these immune evasion mechanisms are driven by TLR2 signaling (62) (63) (64) (65) . In the present study, we show that HKMT can use TLR2 signaling to strongly inhibit cathelicidin expression in DC, and as for autophagy (22, 24) , we find that this attempt to evade the immune system by M. tuberculosis can be counteracted by vitamin D. Thus, although vitamin D reduces IFNγ production, we could conclude that vitamin D does not block Th1 development, and that Th1 cells produce significant amounts of IFNγ in the presence of vitamin D. At the same time, vitamin D is required to upregulate and counteract downregulation of cathelicidin by M. tuberculosis. We believe that these findings add to the understanding of the beneficial role of vitamin D in TB prevention and treatment.
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